183 filings
Page 4 of 10
8-K
iovyssteyhc 9v9
17 Mar 22
AVROBIO Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update
7:54am
8-K
vfbw1e1z zgv9apyb
9 Feb 22
AVROBIO Reports Interim Data from Phase 1/2 Clinical Trial
7:11am
8-K
jk9sxdf8p21roc2xri
7 Jan 22
Cost Associated with Exit or Disposal Activities
4:21pm
8-K
1bwsxn
4 Jan 22
Other Events
7:08am
8-K
j95wu
4 Nov 21
AVROBIO Reports Third Quarter 2021 Financial Results and Provides Business Update
7:32am
8-K
5olx4m h55g0jmnm5
19 Oct 21
AVROBIO Reports New Interim Safety Data Across Investigational Gene Therapies for Fabry and Gaucher Disease Type 1
7:15am
8-K
9a2vhgpqlmd tfca
9 Aug 21
Other Events
9:06am
8-K
pkuv23m
5 Aug 21
AVROBIO Reports Second Quarter 2021 Financial Results and Provides Business Update
7:28am
8-K
32n3kxbwcpe4ruc3
17 Jun 21
Other Events
8:17am
8-K
qx7lnm6nb pgt5na3ca
14 Jun 21
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
xhdxo25wno8yd002rbi
13 May 21
AVROBIO Reports First Quarter 2021 Financial Results and Provides Business Update
7:15am
8-K
9yw zh4mdnp
3 May 21
AVROBIO Provides Regulatory Update on Investigational AVR-RD-01
7:24am
DEFA14A
43td8gy
22 Apr 21
Additional proxy soliciting materials
4:45pm
8-K
0z1dc
23 Mar 21
Regulation FD Disclosure
8:03am
S-8
inzr904gejl3tgo1k
18 Mar 21
Registration of securities for employees
5:25pm